image credit: Pixabay

US scientists identify potential diagnostic tool for Parkinson’s diagnosis

September 30, 2019

The discovery points to the possibility of stopping the progression of Parkinson’s, the second most common neurodegenerative disease, which affects 35 million people globally.

Stanford University School of Medicine associate professor of neurosurgery Xinnan Wang said: “This marker could be used to assess drug candidates’ capacity to counter the defect and stall the disease’s progression.”

The scientists also identified a compound that appears to reverse the defect in cells taken from Parkinson’s patients. In animal models, the compound avoided the death of the neurons whose loss underlies the disease.